AZNAstraZeneca PLC
$159.19+5.4% 1Y
$159.19
$145.5452 weeks$208.62
Is the price fair?
What AZN's price assumes
AstraZeneca PLC trades at 26.2× earnings against 26.2× for the median Drug Manufacturers - General name, cheaper than its own group.
26.2
Trailing P/E · Drug Manufacturers - General median 26.2 · cheaper than the typical name in its group
- Price / sales
- 3.07
Price / sales · as of 2025-Q2
- Price / book
- 4.76
Price / book · as of 2025-Q2
- EV / sales
- 3.44
EV / sales
Details›
- Price / bookas of 2025-Q2
- 4.76
- EV / EBITas of 2025-Q2
- 17.0
- EV / salesas of 2025-Q2
- 3.44
- Healthcare median P/E509 names
- 26.2
- Drug Manufacturers - General median P/E16 names
- 26.2
- Market capitalisation
- $288.0B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, General
Ranks #5 of 7 by RyuScore